Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M142Revenue $M4.5Net Margin (%)-69.9Z-Score-5.1
Enterprise Value $M137EPS $0.4Operating Margin %-64.9F-Score1
P/E(ttm))0Cash Flow Per Share $-0.4Pre-tax Margin (%)-68.1Higher ROA y-yN
Price/Book6.610-y EBITDA Growth Rate %0Quick Ratio2.2Cash flow > EarningsN
Price/Sales5.55-y EBITDA Growth Rate %0Current Ratio2.6Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %2,400ROA % (ttm)-42.7Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-75.0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M16.5ROI % (ttm)54.2Gross Margin Increase y-yN

Gurus Latest Trades with CRME

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
CRMEJulian Robertson 2012-12-31 Sold Out -0.11%$0.25 - $0.5
($0.31)
$ 9.042816%Sold Out0
CRMEGeorge Soros 2011-12-31 Sold Out -0.0008%$1.87 - $3.57
($2.68)
$ 9.04237%Sold Out0
CRMEJulian Robertson 2011-09-30 Reduce-0.69%$3.32 - $5.59
($4)
$ 9.04126%Reduce -22.89%1,952,588
CRMEGeorge Soros 2011-06-30 Buy $3.85 - $5.77
($4.72)
$ 9.0492%New holding, 13200 sh.13,200
CRMEJulian Robertson 2011-03-31 Add0.16%$4.26 - $6.99
($5.9)
$ 9.0453%Add 6.15%2,532,340
CRMEJulian Robertson 2010-12-31 Add0.34%$4.6 - $6.55
($5.6)
$ 9.0461%Add 9.55%2,385,615
CRMEGeorge Soros 2010-12-31 Sold Out $4.6 - $6.55
($5.6)
$ 9.0461%Sold Out0
CRMEJulian Robertson 2010-09-30 Add0.4%$5.97 - $9.31
($7.27)
$ 9.0424%Add 10.01%2,177,615
CRMEJulian Robertson 2010-06-30 Buy 3.53%$6.92 - $8.68
($8.04)
$ 9.0412%New holding, 1979405 sh.1,979,405
CRMEGeorge Soros 2010-06-30 Buy $6.92 - $8.68
($8.04)
$ 9.0412%New holding, 10900 sh.10,900
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

CRME is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


CRME: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Archibald, JenniferSenior Officer 2014-09-08Buy75$7.2924.01view
Hunter, William L.Director, Senior Officer 2014-09-05Buy31,000$6.7434.12view
Archibald, JenniferSenior Officer 2014-09-05Buy3,259$6.734.93view
Archibald, JenniferSenior Officer 2014-09-05Buy100$7.2225.21view
Archibald, JenniferSenior Officer 2014-09-05Buy4,100$7.2524.69view
Hunter, William L.Director, Senior Officer 2014-09-04Buy19,000$6.6535.94view
RIEDER, ROBERTDirector, Director or Senior Officer of Insider or 2014-06-27Sell2,000$8.654.51view
RIEDER, ROBERTDirector, Director or Senior Officer of Insider or 2014-06-26Sell1,500$8.654.51view
RIEDER, ROBERTDirector, Director or Senior Officer of Insider or 2014-06-25Sell2,000$8.644.63view
RIEDER, ROBERTDirector, Director or Senior Officer of Insider or 2014-06-25Sell300$8.634.75view

Press Releases about CRME :

    Quarterly/Annual Reports about CRME:

      News about CRME:

      Articles On GuruFocus.com
      Julian Robertson’s "smart idea, grounded on exhaustive research, followed by a big bet" Jun 24 2011 
      Julian Robertson’s Tiger Management Q1 Portfolio Update May 16 2011 
      Julian Robertson Keeps Buying CRME, Selling AAPL Apr 13 2011 
      More Word of Wisdom from Julian Robertson; Top 2Q10 Purchases: GOOG, EBAY, AAPL, CRME, GS Nov 04 2010 

      More From Other Websites
      8:06 am Cardiome Pharma enters development and commercialization agreement with Eddingpharm for... Dec 21 2014
      Cardiome Enters Development And Commercialization Agreement With Eddingpharm For BrinavessTM In... Dec 19 2014
      Cardiome Enters Development and Commercialization Agreement with Eddingpharm for BRINAVESS™ in... Dec 19 2014
      Mid-Afternoon Market Update: Lions Gate Shares Climb on Report of Dalian Wanda Stake; Crude Oil... Dec 01 2014
      Mid-Day Market Update: ON Semiconductor Surges On $1 Billion Buyback Plan; POZEN Shares Slip Dec 01 2014
      Mid-Morning Market Update: Markets Open Lower; Weatherford To Sell Engineered Chemistry, Drilling... Dec 01 2014
      Cardiome Enters Commercialization Agreement With Aspen For Brinavess In South Africa Nov 17 2014
      Cardiome Enters Commercialization Agreement with Aspen for BRINAVESS® in South Africa Nov 17 2014
      Cardiome Enters Commercialization Agreement with Aspen for BRINAVESS® in South Africa Nov 17 2014
      Canada Stocks to Watch: TMX, InnVest, Brookfield, GMP and more Nov 07 2014
      Cardiome Announces Positive Results From The BRINAVESS® Asia-Pacific Phase 3 Clinical Trial Nov 07 2014
      Cardiome Submits BRINAVESS® Reimbursement Dossier To Italian Authorities To Support Market Access Nov 07 2014
      Cardiome Reports Third Quarter 2014 Financial Results Nov 07 2014
      Cardiome Announces Positive Results from the BRINAVESS® Asia-Pacific Phase 3 Clinical Trial Nov 07 2014
      Cardiome Reports Third Quarter 2014 Financial Results Nov 07 2014
      Cardiome Announces Positive Results from the BRINAVESS® Asia-Pacific Phase 3 Clinical Trial Nov 07 2014
      Cardiome Submits BRINAVESS® Reimbursement Dossier to Italian Authorities to Support Market Access Nov 07 2014
      Cardiome Submits BRINAVESS® Reimbursement Dossier to Italian Authorities to Support Market Access Nov 07 2014
      Cardiome Reports Third Quarter 2014 Financial Results Nov 07 2014
      Cardiome To Hold Third Quarter 2014 Financial Results Conference Call On November 7 Oct 31 2014

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK